Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.2 EUR
1.79 B EUR
16.18 B EUR
1.47 B
About Boston Scientific Corporation
Sector
Industry
CEO
Michael F. Mahoney
Website
Headquarters
Marlborough
Founded
1979
FIGI
BBG000F9XMB6
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.
Speculative Madness: The Market’s Bubble Stocks Some stocks areSpeculative Madness: The Market’s Bubble Stocks
Some stocks aren't just overvalued—they're in full speculative bubble mode. Fundamentals? Irrelevant. When euphoria takes over, rationality disappears.
Here’s my list of bubble stocks that scream unsustainable pricing:
SBUX, T, PLTR, BMY, PYPL, NFLX
BSX heads up at $86.01: Golden Genesis might end rocket trip3 charts show the same fibs in different tf's.
BSX has been a rocket ship for a while.
It has just hit a new Godlen Genesis fib.
The last one held it up for a few months.
It is POSSIBLE that we get a pullback here.
It is PROBABLE that we orbit this a few times.
It is PLAUSIBLE that we break and co
$BSX with a bullish outlook following its earnings #StocksThe PEAD projected a bullish outlook for NYSE:BSX after a negative under reaction following its earnings release placing the stock in drift D with an expected accuracy of 83.33%.
Morning Overview: Pullback and Anti Pattern's To Trade TodayThis morning I covered the overview of AMEX:SPY $AMEX:DIA. I talked about pattern recognition across markets, I gave valuable insight into potential pullbacks and anti patterns that are setting up. I provide entry ideas and mentioned the stocks that I like for trading today. Many of which were sho
Boston Scientific - interesting formationBSX share price looks like it will go more to the upside. Especially after BSX reported its 1Q 2024 financial results and lifted up full year 2024 financial guidance.
Another positive trigger will occur end of May - June as the company should announced completion of the acquisition of Axonics (AXNX)
Confirmed cup and handle pattern on BSX chartHi,
please see the following chart pattern, that has been confirmed in the last weeks.
Accordingly to the rules of the pattern, the price target is about 70$.
If doesn't will come a market crash, there is a good opportunity, to reach the TP.
The price action is supported with the AI hype, that is e
🏥💼 Boston Scientific (BSX) Investment Analysis 💡📈Strategic Acquisitions:
Boston Scientific's recent acquisitions, including Axonics, Relievant Medsystems, and partial offer for Acotec, signify its proactive expansion strategy, targeting new growth opportunities in medical segments and lucrative markets like China.
Innovative Product Introductions
BSX - Short IdeaI believe BSX had a good run up the past couple of weeks. And by looking at how its finding resistance at the top key levels, I expect to have a potential move down to $54 area. Again, risk management is key. Expected return vs risk is important. Always keep that in mind. The markets are choppy so y
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
BSX4801034
Boston Scientific Corporation 4.7% 01-MAR-2049Yield to maturity
6.21%
Maturity date
Mar 1, 2049
BSX4988125
Boston Scientific Corporation 1.9% 01-JUN-2025Yield to maturity
6.12%
Maturity date
Jun 1, 2025
BSX4801033
Boston Scientific Corporation 4.55% 01-MAR-2039Yield to maturity
5.63%
Maturity date
Mar 1, 2039
BSX.GJ
Boston Scientific Corporation 7.375% 15-JAN-2040Yield to maturity
5.39%
Maturity date
Jan 15, 2040
BSX4988126
Boston Scientific Corporation 2.65% 01-JUN-2030Yield to maturity
4.92%
Maturity date
Jun 1, 2030
BSX4800733
Boston Scientific Corporation 4.0% 01-MAR-2029Yield to maturity
4.60%
Maturity date
Mar 1, 2029
BSX4800732
Boston Scientific Corporation 3.75% 01-MAR-2026Yield to maturity
4.38%
Maturity date
Mar 1, 2026
BSX4602368
Boston Scientific Corporation 4.0% 01-MAR-2028Yield to maturity
4.28%
Maturity date
Mar 1, 2028
CH0A
AMERICAN MEDICAL SYSTEMS EUROPE B.V. 2022-08.03.34 GUARANTEEDYield to maturity
3.66%
Maturity date
Mar 8, 2034
See all BSX bonds
Related stocks
Frequently Asked Questions
The current price of BSX is 83.4 EUR — it has increased by 2.18% in the past 24 hours. Watch BOSTON SCIENTIFIC DL-,01 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange BOSTON SCIENTIFIC DL-,01 stocks are traded under the ticker BSX.
BSX stock has fallen by −5.39% compared to the previous week, the month change is a −7.47% fall, over the last year BOSTON SCIENTIFIC DL-,01 has showed a 32.38% increase.
We've gathered analysts' opinions on BOSTON SCIENTIFIC DL-,01 future price: according to them, BSX price has a max estimate of 117.29 EUR and a min estimate of 92.10 EUR. Watch BSX chart and read a more detailed BOSTON SCIENTIFIC DL-,01 stock forecast: see what analysts think of BOSTON SCIENTIFIC DL-,01 and suggest that you do with its stocks.
BSX stock is 4.73% volatile and has beta coefficient of 0.87. Track BOSTON SCIENTIFIC DL-,01 stock price on the chart and check out the list of the most volatile stocks — is BOSTON SCIENTIFIC DL-,01 there?
Today BOSTON SCIENTIFIC DL-,01 has the market capitalization of 120.26 B, it has decreased by −5.47% over the last week.
Yes, you can track BOSTON SCIENTIFIC DL-,01 financials in yearly and quarterly reports right on TradingView.
BOSTON SCIENTIFIC DL-,01 is going to release the next earnings report on Apr 23, 2025. Keep track of upcoming events with our Earnings Calendar.
BSX earnings for the last quarter are 0.68 EUR per share, whereas the estimation was 0.63 EUR resulting in a 6.52% surprise. The estimated earnings for the next quarter are 0.62 EUR per share. See more details about BOSTON SCIENTIFIC DL-,01 earnings.
BOSTON SCIENTIFIC DL-,01 revenue for the last quarter amounts to 4.41 B EUR, despite the estimated figure of 4.27 B EUR. In the next quarter, revenue is expected to reach 4.23 B EUR.
BSX net income for the last quarter is 546.74 M EUR, while the quarter before that showed 421.23 M EUR of net income which accounts for 29.80% change. Track more BOSTON SCIENTIFIC DL-,01 financial stats to get the full picture.
No, BSX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 23, 2025, the company has 53 K employees. See our rating of the largest employees — is BOSTON SCIENTIFIC DL-,01 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BOSTON SCIENTIFIC DL-,01 EBITDA is 3.79 B EUR, and current EBITDA margin is 23.31%. See more stats in BOSTON SCIENTIFIC DL-,01 financial statements.
Like other stocks, BSX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BOSTON SCIENTIFIC DL-,01 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BOSTON SCIENTIFIC DL-,01 technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BOSTON SCIENTIFIC DL-,01 stock shows the buy signal. See more of BOSTON SCIENTIFIC DL-,01 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.